Haemonetics
296 hedge funds and large institutions have $5.49B invested in Haemonetics in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 101 increasing their positions, 105 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
0.29% less ownership
Funds ownership: 97.89% → 97.6% (-0.29%)
4% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 105
7% less capital invested
Capital invested by funds: $5.89B → $5.49B (-$398M)
Holders
296
Holding in Top 10
3
Calls
$11M
Puts
$10M
Top Buyers
| 1 | +$94.6M | |
| 2 | +$64.4M | |
| 3 | +$25.2M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$23.2M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
+$14.9M |
Top Sellers
| 1 | -$73.9M | |
| 2 | -$47.7M | |
| 3 | -$46.4M | |
| 4 |
Renaissance Technologies
New York
|
-$32.9M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$32M |